$5.14
-0.19-3.56%
At Close: -
$5.17
0.030.58%
After Hours: 5:32 PM EDT
15 minutes delayed
Prime Medicine
PRMENASDAQ
Prime Medicine (PRME) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPrime Medicine (NASDAQ:PRME) Stock Quotes, Forecast and News Summary
Prime Medicine Stock (NASDAQ: PRME) stock price, news, charts, stock research, profile.
| Open | $5.33 |
| Close | $5.14 |
| Volume / Avg. | 3.57M / 901.31K |
| Day Range | 4.99 - 5.36 |
| 52 Wk Range | 4.11 - 15.75 |
| Market Cap | $620.56M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 20.25% |
| Days to Cover | 13.03 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Prime Medicine Inc
Sector
Health Care
Industry
Biotechnology
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address d...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prime Medicine (PRME) stock?
You can purchase shares of Prime Medicine (NASDAQ:PRME) through any online brokerage.
Who are Prime Medicine (PRME) competitors?
Other companies in Prime Medicine’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Sage Therapeutics (NASDAQ:SAGE) and AnaptysBio (NASDAQ:ANAB).
What is the target price for Prime Medicine (PRME) stock?
There is no analysis for Prime Medicine.
What is the forecast for Prime Medicine (PRME) stock?
Prime Medicine has a consensus price target of $15.86.
Current stock price for Prime Medicine (PRME)?
The stock price for Prime Medicine (NASDAQ: PRME) is $5.17 last updated June 28, 2024 at 5:32 PM EDT.
Does Prime Medicine (PRME) pay a dividend?
A quarterly cash dividend of 0.80 per share of Class A Common Stock. The quarterly cash dividend was payable on September 12, 2019 to stockholders of record on September 10, 2019.
When is Prime Medicine (NASDAQ:PRME) reporting earnings?
Prime Medicine’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Prime Medicine (PRME) going to split?
There is no upcoming split for Prime Medicine.
What sector and industry does Prime Medicine (PRME) operate in?
Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.